Godsey & Gibb Inc’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.4K Hold
66
﹤0.01% 218
2026
Q1
$19.2K Hold
66
﹤0.01% 238
2025
Q4
$23K Hold
66
﹤0.01% 228
2025
Q3
$21.2K Hold
66
﹤0.01% 217
2025
Q2
$25.6K Hold
66
﹤0.01% 201
2025
Q1
$28.6K Hold
66
﹤0.01% 202
2024
Q4
$24.2K Sell
66
-20
-23% -$8.37K ﹤0.01% 212
2024
Q3
$44.6K Hold
86
﹤0.01% 190
2024
Q2
$46.4K Hold
86
﹤0.01% 189
2024
Q1
$44.4K Hold
86
﹤0.01% 171
2023
Q4
$40.4K Hold
86
﹤0.01% 177
2023
Q3
$37.3K Sell
86
-20
-19% -$9.07K ﹤0.01% 179
2023
Q2
$47K Sell
106
-20
-16% -$9.23K 0.01% 172
2023
Q1
$57.8K Buy
+126
New +$60K 0.01% 157
2022
Q2
Sell
-126
Closed -$62K 118
2022
Q1
$62K Sell
126
-36
-22% -$16.5K 0.02% 48
2021
Q4
$75K Buy
+162
New +$68.2K 0.02% 46

Other funds holding ELV

Godsey & Gibb Inc's ELV Position: Q2 2026 in Review

Godsey & Gibb Inc held its Elevance Health (ELV) position steady in Q2 2026 at 66 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #218.

Godsey & Gibb Inc first reported a position in ELV in Q4 2021 and has held it in 16 quarters since. The position peaked at $75K in Q4 2021. 478 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Godsey & Gibb Inc held 66 shares of Elevance Health worth $25.4K as of Q2 2026.
  • Godsey & Gibb Inc left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Godsey & Gibb Inc's portfolio in Q2 2026, its #218 holding.
  • Godsey & Gibb Inc first reported a position in Elevance Health in Q4 2021 and has held it in 16 quarters since.
  • Godsey & Gibb Inc's Elevance Health position peaked at $75K in Q4 2021.
  • 478 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Godsey & Gibb Inc's 13F filing for Q2 2026, filed 13 Jul 2026.